Michael C. Heinrich, MD - Refining Treatment Based on Molecular Characterization of Gastrointestinal Stromal Tumors: What Does the Latest Evidence Show?

Summary: In this program, an expert summarizes current evidence on prognostic and predictive factors in gastrointestinal stromal tumors (GIST), discusses when and how to use mutational analysis in clinical practice, and reviews novel agents and combinations being evaluated in the advanced disease, as well as the emerging role of targeted therapies in patients with early stage GIST.